[
  {
    "ts": null,
    "headline": "Revvity: Close To A Buy, Not Quite There",
    "summary": "Revvity, Inc. is rated a Hold due to stretched valuation, ongoing weakness in China diagnostics and NIH funding. Read more on RVTY stock here.",
    "url": "https://finnhub.io/api/news?id=8c9aebc69c957cb5511dc5f08bfbb0df7202cbeb6f17869ad668d4577cb1fdb2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770125752,
      "headline": "Revvity: Close To A Buy, Not Quite There",
      "id": 138344866,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1358567692/image_1358567692.jpg?io=getty-c-w1536",
      "related": "RVTY",
      "source": "SeekingAlpha",
      "summary": "Revvity, Inc. is rated a Hold due to stretched valuation, ongoing weakness in China diagnostics and NIH funding. Read more on RVTY stock here.",
      "url": "https://finnhub.io/api/news?id=8c9aebc69c957cb5511dc5f08bfbb0df7202cbeb6f17869ad668d4577cb1fdb2"
    }
  }
]